| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $337.6M | +1.7% |
| Cost of Revenue | $128.7M | +4.0% |
| Gross Profit | $208.9M | +0.4% |
| R&D Expense | $204.9M | +22.5% |
| SG&A Expense | $78.2M | +11.1% |
| Operating Income | -$74.3M | -150.5% |
| Pre-tax Income | -$70.9M | -147.7% |
| Income Tax | -$5.6M | -149.0% |
| Net Income | -$65.4M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $113.5M | -33.6% |
| Accounts Receivable | $52.0M | +17.3% |
| Inventory | $40.5M | -10.5% |
| Current Assets | $304.6M | +14.2% |
| Total Assets | $710.2M | +8.0% |
| Current Liabilities | $83.5M | -6.5% |
| Total Liabilities | $104.1M | -5.7% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $44.1M | +13.7% |
| Investing Cash Flow | -$107.3M | +10.3% |
| Financing Cash Flow | $5.7M | -45.9% |
| -147.6% |
| EPS (Basic) | -$1.70 | -136.1% |
| EPS (Diluted) | -$1.70 | -136.1% |
| Stockholders' Equity |
| $606.1M |
| +10.8% |